MDM2 and MDMX can interact differently with ARF and members of the p53 family

被引:73
|
作者
Wang, XQ
Arooz, T
Siu, WY
Chiu, CHS
Lau, A
Yamashita, K
Poon, RYC
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Life Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
ARF; MDM2; MDMX; p53; p63; p73; tumor suppressor;
D O I
10.1016/S0014-5793(01)02124-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the p53 family of transcription factors have essential roles in tumor suppression and in development, MDM2 is an essential regulator of p53 that can inhibit the transcriptional activity of p53, shuttle p53 out of the nucleus, and target p53 for ubiquitination-mediated degradation. Little is known about the interaction and selectivity of different members of the p53 family (p53, p63, and p73) and the MDM2 family (MDM2 and MDMX). Here we show that the transcriptional activities of p53 and p73, but not that of p63, were inhibited by both MDM2 and MDMX. Consistent with these, we found that MDMX can physically interact with p53 and p73, but not with p63, Moreover, ectopically expressed MDM2 and MDMX could induce alterations in the subcellular localization of p73, but did not affect the subcellular localization of p53 and p63. Finally, we demonstrate that while ARF can interact with MDM2 and inhibit the regulation of p53 by MDM2. no interaction was found between ARF and MDMX. These data reveal that significant differences and selectivity exist between the regulation of different members of the p53 family by MDM2 and MDMX. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [21] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [22] Structural Adaptation of Secondary p53 Binding Sites on MDM2 and MDMX
    Higbee, Pirada Serena
    Dayhoff II, Guy W.
    Anbanandam, Asokan
    Varma, Sameer
    Daughdrill, Gary
    JOURNAL OF MOLECULAR BIOLOGY, 2024, 436 (13)
  • [23] Parallel discovery of multiple chemotypes antagonizing p53/mdm2/mdmx
    Alexander, Doemling
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3422S - 3422S
  • [24] Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
    Ohtsubo, Chihiro
    Shiokawa, Daisuke
    Kodama, Masami
    Gaiddon, Christian
    Nakagama, Hitoshi
    Jochemsen, Aart G.
    Taya, Yoichi
    Okamoto, Koji
    CANCER SCIENCE, 2009, 100 (07): : 1291 - 1299
  • [25] The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
    Liren Jiang
    Joanna Zawacka-Pankau
    Cell Death & Disease, 11
  • [26] On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins
    ElSawy, Karim M.
    Verma, Chandra S.
    Joseph, Thomas L.
    Lane, David P.
    Twarock, Reidun
    Caves, Leo S. D.
    CELL CYCLE, 2013, 12 (03) : 394 - 404
  • [27] Differential binding of p53 and nutlin to MDM2 and MDMX Computational studies
    Joseph, Thomas Leonard
    Madhumalar, Arumugam
    Brown, Christopher John
    Lane, David P.
    Verma, Chandra
    CELL CYCLE, 2010, 9 (06) : 1167 - 1181
  • [28] p53 regulation Teamwork between RING domains of Mdm2 and MdmX
    Wang, Xinjiang
    CELL CYCLE, 2011, 10 (24) : 4225 - 4229
  • [29] DISRUPTION OF P53/MDM2/MDMX PROTEIN-PROTEIN INTERACTIONS
    Topper, M.
    Zhou, M.
    Anderson, L.
    McLaughlin, M.
    BIOPOLYMERS, 2009, 92 (04) : 332 - 332
  • [30] MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin
    Hu, Baoli
    Gilkes, Daniele M.
    Farooqi, Bilal
    Sebti, Said M.
    Chen, Jiandong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) : 33030 - 33035